Ictal-interictal continuum abnormalities (IICAs) are common after subarachnoid hemorrhage (SAH). IICAs are associated with higher risk for delayed cerebral ischemia (DCI), especially if they emerge late in the acute period after SAH. Quantification of IICA features may assist in the development of an algorithm to predict DCI risk.
i g h l i g h t s
Ictal-interictal continuum abnormalities (IICAs) are common after subarachnoid hemorrhage (SAH). IICAs are associated with higher risk for delayed cerebral ischemia (DCI), especially if they emerge late in the acute period after SAH. Quantification of IICA features may assist in the development of an algorithm to predict DCI risk.
a b s t r a c t
Objective: To identify whether abnormal neural activity, in the form of epileptiform discharges and rhythmic or periodic activity, which we term here ictal-interictal continuum abnormalities (IICAs), are associated with delayed cerebral ischemia (DCI). Methods: Retrospective analysis of continuous electroencephalography (cEEG) reports and medical records from 124 patients with moderate to severe grade subarachnoid hemorrhage (SAH). We identified daily occurrence of seizures and IICAs. Using survival analysis methods, we estimated the cumulative probability of IICA onset time for patients with and without delayed cerebral ischemia (DCI). Results: Our data suggest the presence of IICAs indeed increases the risk of developing DCI, especially when they begin several days after the onset of SAH. We found that all IICA types except generalized rhythmic delta activity occur more commonly in patients who develop DCI. In particular, IICAs that begin later in hospitalization correlate with increased risk of DCI.
Conclusions: IICAs represent a new marker for identifying early patients at increased risk for DCI. Moreover, IICAs might contribute mechanistically to DCI and therefore represent a new potential target for intervention to prevent secondary cerebral injury following SAH. Significance: These findings imply that IICAs may be a novel marker for predicting those at higher risk for DCI development. Ó 2017 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.
